Local Application of a New Chalconic Derivative (Chalcone T4) Reduces Inflammation and Oxidative Stress in a Periodontitis Model in Rats
- PMID: 39456446
- PMCID: PMC11504102
- DOI: 10.3390/antiox13101192
Local Application of a New Chalconic Derivative (Chalcone T4) Reduces Inflammation and Oxidative Stress in a Periodontitis Model in Rats
Abstract
Chalcones are phenolic compounds with biological properties. This study had the aim to evaluate the effects of topical administration of a new synthetic chalcone, Chalcone T4, in an animal model of periodontitis induced by ligature. Forty rats were distributed in the following experimental groups: negative control (without periodontitis and topical application of distilled water), positive control (periodontitis and topical application of distilled water), chalcone I and II (periodontitis and topical application of 0.6 mg/mL and 1.8 mg/mL, respectively). Chalcone or distilled water was administered into the gingival sulcus of the first molars daily for 10 days, starting with the ligature installation. The following outcomes were evaluated: alveolar bone loss (µCT and methylene blue dye staining), quantification of osteoclasts (histomorphometry), cell infiltrate and collagen content (stereometry), gene expression of mediators (Nfact11, Tnf-α, Mmp-13, iNos, Sod and Nrf2) by (RT-qPCR); expression of BCL-2 and Caspase-1 (immunohistochemistry). Chalcone T4 inhibited bone resorption and prevented collagen matrix degradation. Reduction in the expression of inflammatory markers (Nfact11, Tnf-α, Mmp-13, and Caspase-1), attenuation of oxidative stress (iNOS reduction, and increase in Sod), and pro-apoptotic effect of the compound (BCL-2 reduction), were associated its effects on periodontal tissues. Topical application of Chalcone T4 prevented bone resorption and inflammation, demonstrating potential in the adjunctive treatment of periodontitis.
Keywords: antioxidant activity; chalcone; periodontitis; topical application.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Chalcone T4, a novel chalconic compound, inhibits inflammatory bone resorption in vivo and suppresses osteoclastogenesis in vitro.J Periodontal Res. 2021 Jun;56(3):569-578. doi: 10.1111/jre.12857. Epub 2021 Feb 28. J Periodontal Res. 2021. PMID: 33641160
-
Effects of theaflavins on tissue inflammation and bone resorption on experimental periodontitis in rats.J Periodontal Res. 2018 Dec;53(6):1009-1019. doi: 10.1111/jre.12600. Epub 2018 Aug 30. J Periodontal Res. 2018. PMID: 30159985 Free PMC article.
-
Nootkatone mitigates periodontal inflammation and reduces alveolar bone loss via Nrf2/HO-1 and NF-κB pathways in rat model of periodontitis.Folia Histochem Cytobiol. 2024;62(3):145-153. doi: 10.5603/fhc.101862. Epub 2024 Aug 28. Folia Histochem Cytobiol. 2024. PMID: 39192685
-
Protective effects of desipramine on alveolar bone in experimental periodontitis.J Periodontol. 2020 Dec;91(12):1694-1703. doi: 10.1002/JPER.19-0569. Epub 2020 Jun 5. J Periodontol. 2020. PMID: 32294250 Free PMC article.
-
Toward the use of Boesenbergia rotunda extracts and the chalcone panduratin A to treat periodontitis.J Oral Biosci. 2022 Jun;64(2):183-192. doi: 10.1016/j.job.2022.03.002. Epub 2022 Mar 17. J Oral Biosci. 2022. PMID: 35306173 Review.
Cited by
-
The role of plant-based dietary compounds in gut microbiota modulation in inflammatory bowel disease.Front Nutr. 2025 May 30;12:1606289. doi: 10.3389/fnut.2025.1606289. eCollection 2025. Front Nutr. 2025. PMID: 40521353 Free PMC article. Review.
References
-
- Alexander M.B., Damoulis P.D. The role of cytokines in the pathogenesis of periodontal disease. Curr. Opin. Periodontol. 1994:39–53. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources